IL88363A0 - Fluorocytidine derivatives,their production and pharmaceutical compositions containing them - Google Patents

Fluorocytidine derivatives,their production and pharmaceutical compositions containing them

Info

Publication number: IL88363A0
Authority: IL; Israel
Prior art keywords: production; pharmaceutical compositions; compositions containing; fluorocytidine derivatives; fluorocytidine
Prior art date: 1987-11-17

Application number

IL88363A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-17

Filing date

1988-11-11

Publication date

1989-06-30

1988-11-11 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1989-06-30 Publication of IL88363A0 publication Critical patent/IL88363A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

IL88363A 1987-11-17 1988-11-11 Fluorocytidine derivatives,their production and pharmaceutical compositions containing them IL88363A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP87116926		1987-11-17

Publications (1)

Publication Number	Publication Date
IL88363A0 true IL88363A0 (en)	1989-06-30

Family

ID=8197450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL88363A IL88363A0 (en)	1987-11-17	1988-11-11	Fluorocytidine derivatives,their production and pharmaceutical compositions containing them

Country Status (35)

Country	Link
US (1)	US4966891A (fi)
EP (1)	EP0316704B1 (fi)
JP (1)	JPH0678350B2 (fi)
KR (1)	KR970000241B1 (fi)
CN (1)	CN1022688C (fi)
AR (1)	AR247217A1 (fi)
AT (1)	ATE124951T1 (fi)
AU (1)	AU619220B2 (fi)
CA (1)	CA1327358C (fi)
CS (1)	CS274486B2 (fi)
DE (2)	DE10199027I2 (fi)
DK (1)	DK170893B1 (fi)
DZ (1)	DZ1270A1 (fi)
ES (1)	ES2074429T3 (fi)
FI (1)	FI89804C (fi)
GR (1)	GR3017686T3 (fi)
HK (1)	HK1003114A1 (fi)
HU (1)	HU199866B (fi)
IE (1)	IE883430L (fi)
IL (1)	IL88363A0 (fi)
IS (1)	IS1895B (fi)
LT (1)	LT2185B (fi)
LU (1)	LU90769I2 (fi)
LV (1)	LV5624A3 (fi)
MC (1)	MC1992A1 (fi)
MX (1)	MX173347B (fi)
NL (1)	NL300045I2 (fi)
NO (2)	NO171167C (fi)
NZ (1)	NZ226923A (fi)
PH (1)	PH25641A (fi)
PT (1)	PT89009B (fi)
SU (1)	SU1736342A3 (fi)
UA (1)	UA19333A (fi)
YU (1)	YU47122B (fi)
ZA (1)	ZA888428B (fi)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6258360B1 (en) *	1989-05-04	2001-07-10	Igen International, Inc.	Prodrugs activated by targeted catalytic proteins
US5527782A (en) *	1990-03-13	1996-06-18	Acic (Canada) Inc.	5-halo-2,3'-O-cyclocytidines
TW254946B (fi) *	1992-12-18	1995-08-21	Hoffmann La Roche
AU671491B2 (en) *	1992-12-18	1996-08-29	F. Hoffmann-La Roche Ag	N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
US5476932A (en) *	1994-08-26	1995-12-19	Hoffmann-La Roche Inc.	Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
IT1291983B1 (it) *	1997-05-23	1999-01-25	Pro Bio Sint Srl	Prodcedimento per la preparazione di un derivato della desossiuridina
NZ330360A (en) *	1997-06-02	1999-03-29	Hoffmann La Roche	5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) *	1997-06-02	2009-08-26	F. Hoffmann-La Roche Ag	5'-Deoxy-cytidine derivatives
US6005098A (en) *	1998-02-06	1999-12-21	Hoffmann-La Roche Inc.	5'deoxycytidine derivatives
US20080113025A1 (en) *	1998-11-02	2008-05-15	Elan Pharma International Limited	Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20010051348A1 (en) *	2000-01-28	2001-12-13	Lee Chee Wee	Novel ligands and methods for preparing same
SE0102764D0 (sv)	2001-08-17	2001-08-17	Astrazeneca Ab	Compounds
CA2477088A1 (en)	2002-02-22	2003-10-02	New River Pharmaceuticals Inc.	Active agent delivery systems and methods for protecting and administering active agents
US6774758B2 (en) *	2002-09-11	2004-08-10	Kalyan P. Gokhale	Low harmonic rectifier circuit
GB0226930D0 (en)	2002-11-19	2002-12-24	Astrazeneca Ab	Chemical compounds
AU2003233586A1 (en) *	2003-05-20	2005-01-21	Aronex Pharmaceuticals, Inc.	Combination chemotherapy comprising capecitabine and a liposomal platinum complex
ATE402185T1 (de) *	2003-12-22	2008-08-15	Hoffmann La Roche	Verfahren für fluorcytidinderivate
US20080312207A1 (en) *	2004-02-18	2008-12-18	Craig Johnstone	Compounds
RU2392275C2 (ru) *	2004-02-18	2010-06-20	Астразенека Аб	Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов
CN100383128C (zh) *	2004-02-23	2008-04-23	上海迪赛诺医药发展有限公司	N4－氧羰基胞嘧啶衍生物及制备方法与应用
TW200600086A (en) *	2004-06-05	2006-01-01	Astrazeneca Ab	Chemical compound
KR101061850B1 (ko)	2004-09-08	2011-09-02	삼성전자주식회사	박막 트랜지스터 표시판 및 그 제조방법
GB0421294D0 (en) *	2004-09-24	2004-10-27	Angiogene Pharm Ltd	Bioreductively-activated prodrugs
US7700640B2 (en)	2004-10-16	2010-04-20	Astrazeneca Ab	Process for making phenoxy benzamide compounds
GB0423043D0 (en) *	2004-10-16	2004-11-17	Astrazeneca Ab	Compounds
KR101313702B1 (ko)	2005-02-03	2013-10-04	와이어쓰	제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물
NO322682B1 (no) *	2005-03-18	2006-11-27	Clavis Pharma Asa	Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
EP1868608A2 (en) *	2005-04-01	2007-12-26	F. Hoffmann-Roche AG	Method for administration of capecitabine
US20110059941A1 (en) *	2005-05-24	2011-03-10	Peter William Rodney Caulkett	2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en)	2005-05-27	2007-04-16	Astrazeneca Ab	Chemical compounds
EP2027113A1 (en) *	2005-07-09	2009-02-25	AstraZeneca AB	Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
EP1910350A1 (en) *	2005-07-09	2008-04-16	AstraZeneca AB	2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
JP4651714B2 (ja)	2005-07-09	2011-03-16	アストラゼネカアクチボラグ	糖尿病の治療においてｇｌｋ活性化剤として使用するためのヘテロアリールベンズアミド誘導体
CN100569790C (zh) *	2005-07-15	2009-12-16	上海奥锐特国际贸易有限公司	合成n4-酰基-5＇-脱氧-5-氟胞苷衍生物的方法
US20080292729A1 (en) *	2005-07-21	2008-11-27	Nuvo Research Inc.	Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment
US9202182B2 (en) *	2005-08-11	2015-12-01	International Business Machines Corporation	Method and system for analyzing business architecture
TW200803892A (en)	2005-11-04	2008-01-16	Wyeth Corp	Antineoplastic combinations with MTOR inhibitor, herceptin, and/or HKI-272
TW200738621A (en)	2005-11-28	2007-10-16	Astrazeneca Ab	Chemical process
US20080085310A1 (en) *	2006-10-06	2008-04-10	Maria Oksana Bachynsky	Capecitabine rapidly disintegrating tablets
TW200825063A (en)	2006-10-23	2008-06-16	Astrazeneca Ab	Chemical compounds
CL2007003061A1 (es)	2006-10-26	2008-08-01	Astrazeneca Ab	Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
CN100425617C (zh) *	2006-10-31	2008-10-15	浙江海正药业股份有限公司	一种含氟嘧啶类化合物烷氧羰酰化的方法
JP2010513445A (ja)	2006-12-21	2010-04-30	アストラゼネカアクチボラグ	Ｇｌｋアクチベーターとして有用な新規結晶性化合物
ITMI20070435A1 (it)	2007-03-05	2008-09-06	Innovate Biotechnology Srl	2',3'-di-o-acil-5-fluoronucleosidi
EP2137201A2 (en) *	2007-04-20	2009-12-30	Dr. Reddy's Laboratories Ltd.	Process for preparing capecitabine
WO2008145403A1 (en) *	2007-06-01	2008-12-04	Synthon B.V.	Processes related to making capecitabine
WO2009042064A2 (en)	2007-09-21	2009-04-02	Nektar Therapeutics Al, Corporation	Oligomer-nucleoside phosphate conjugates
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
WO2009088989A1 (en) *	2008-01-03	2009-07-16	Plus Chemicals, S.A.	Process for the preparation of capecitabine
DK2310011T3 (da)	2008-06-17	2013-10-14	Wyeth Llc	Antineoplastiske kombinationer indeholdende hki-272 og vinorelbin
EP2324028A2 (en)	2008-08-04	2011-05-25	AstraZeneca AB	Therapeutic agents 414
KR101434009B1 (ko) *	2008-08-04	2014-08-25	와이어쓰 엘엘씨	4-아닐리노-3-사이아노퀴놀린과 카페시타빈의 항신생물성 조합물
WO2010065586A2 (en) *	2008-12-02	2010-06-10	Dr. Reddy's Laboratories Ltd.	Preparation of capecitabine
WO2010063080A1 (en)	2008-12-05	2010-06-10	Commonwealth Scientific And Industrial Research Organisation	Amphiphile prodrugs
CN101787066B (zh) *	2009-01-23	2013-07-31	高峰	阿糖胞苷衍生物及其在抗癌抗肿瘤中的用途
GB0902434D0 (en)	2009-02-13	2009-04-01	Astrazeneca Ab	Chemical process
GB0902406D0 (en)	2009-02-13	2009-04-01	Astrazeneca Ab	Crystalline polymorphic form
US9211291B2 (en)	2009-04-06	2015-12-15	Wyeth Llc	Treatment regimen utilizing neratinib for breast cancer
AR076221A1 (es) *	2009-04-09	2011-05-26	Astrazeneca Ab	Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2010116177A1 (en)	2009-04-09	2010-10-14	Astrazeneca Ab	A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
CN101875680B (zh) *	2009-04-28	2012-07-25	上海信旗医药科技有限公司	一种核苷类化合物及其制备方法和应用
WO2011010967A1 (en) *	2009-07-23	2011-01-27	Scinopharm Taiwan Ltd.	Process for producing flurocytidine derivatives
DK2835053T3 (en)	2010-03-12	2016-08-15	Genzyme Corp	Combination therapy to treat breast cancer
AU2013243949A1 (en)	2012-04-02	2014-10-30	Moderna Therapeutics, Inc.	Modified polynucleotides for the production of biologics and proteins associated with human disease
HK1206779A1 (en)	2012-04-02	2016-01-15	Modernatx, Inc.	Modified polynucleotides for the production of nuclear proteins
KR102281288B1 (ko)	2012-09-26	2021-07-26	에프. 호프만-라 로슈 아게	환형 에터 피라졸-4-일-헤테로사이클릴-카복사마이드 화합물 및 이의 사용 방법
US9447137B2 (en)	2012-11-07	2016-09-20	Nucorion Pharmaceuticals, Inc.	Substituted gemcitabine aryl amide analogs
US10138507B2 (en)	2013-03-15	2018-11-27	Modernatx, Inc.	Manufacturing methods for production of RNA transcripts
WO2014145207A1 (en) *	2013-03-15	2014-09-18	Ohio State Innovation Foundation	Substituted gemcitabine bicyclic amide analogs and treatment methods using same
EP3041938A1 (en)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Circular polynucleotides
US20160194625A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Chimeric polynucleotides
CN103450301B (zh) *	2013-09-09	2015-09-09	南通大学	法尼基硫代水杨酸-核苷缀合物、其制备方法及其医药用途
WO2015051214A1 (en)	2013-10-03	2015-04-09	Moderna Therapeutics, Inc.	Polynucleotides encoding low density lipoprotein receptor
RU2770081C2 (ru) *	2016-06-28	2022-04-14	Селликс Био Прайвет Лимитед	Композиции и способы для лечения рака
EP4046989A1 (en)	2017-01-09	2022-08-24	Shuttle Pharmaceuticals, Inc.	Selective histone deacetylase inhibitors for the treatment of human disease
US11584733B2 (en)	2017-01-09	2023-02-21	Shuttle Pharmaceuticals, Inc.	Selective histone deacetylase inhibitors for the treatment of human disease
WO2018200859A1 (en)	2017-04-26	2018-11-01	Kalman Thomas I	Multitargeted nucleoside derivatives
US10435429B2 (en)	2017-10-03	2019-10-08	Nucorion Pharmaceuticals, Inc.	5-fluorouridine monophosphate cyclic triester compounds
US11407723B2 (en)	2018-01-09	2022-08-09	Shuttle Pharmaceuticals, Inc.	Selective histone deacetylase inhibitors for the treatment of human disease
CN117402189A (zh)	2018-01-10	2024-01-16	广东集宝医药技术有限公司	氨基磷(膦)酸缩醛和磷(膦)酸缩醛化合物
US11427550B2 (en)	2018-01-19	2022-08-30	Nucorion Pharmaceuticals, Inc.	5-fluorouracil compounds
CN111801339B (zh) *	2018-01-19	2025-06-24	纽科利制药公司	5-氟尿嘧啶化合物
WO2020026054A1 (en) *	2018-08-03	2020-02-06	Cellix Bio Private Limited	Compositions and methods for the treatment of cancer
CN109651467A (zh) *	2019-01-15	2019-04-19	齐鲁天和惠世制药有限公司	一种卡培他滨杂质及其制备方法
US12110311B2 (en)	2019-07-17	2024-10-08	Nucorion Pharmaceuticals, Inc.	Cyclic deoxyribonucleotide compounds
WO2021216427A1 (en)	2020-04-21	2021-10-28	Ligand Pharmaceuticals, Inc.	Nucleotide prodrug compounds
EP4185274A1 (en)	2020-07-24	2023-05-31	Strand Therapeutics Inc.	Lipidnanoparticle comprising modified nucleotides
AR124599A1 (es)	2021-01-08	2023-04-12	Strand Therapeutics Inc	Constructos de expresión y usos de estos
JP2025516226A (ja)	2022-04-26	2025-05-27	ストランドセラピューティクスインコーポレイテッド	ベネズエラウマ脳炎（ｖｅｅ）レプリコンを含む脂質ナノ粒子及びその使用
WO2025193628A2 (en)	2024-03-09	2025-09-18	Aadigen, Llc	Compositions for treating cancer with kras mutations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3404144A (en) *	1965-12-23	1968-10-01	Research Corp	1-beta-d-arabinofuranosyl-5-fluorocytosine compounds
GB1379410A (en) *	1971-06-08	1975-01-02	Upjohn Co	1-beta-d-arabino-furanosyl-n4-alpha-aminoacylcytosines
JPS52153977A (en) *	1976-06-11	1977-12-21	Daikin Ind Ltd	Synthesis of 5-fluorouracil and its derivatives
US4071680A (en) *	1976-12-20	1978-01-31	Hoffmann-La Roche Inc.	5'-Deoxy-5-fluoropyrimidine nucleosides
CH633810A5 (en) *	1978-01-01	1982-12-31	Hoffmann La Roche	Novel nucleosides and process for their preparation
FR2528311B1 (fr) *	1982-06-14	1985-06-14	Synthelabo	Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
JPS61112093A (ja) *	1984-11-05	1986-05-30	Wakunaga Seiyaku Kk	ヌクレオチド誘導体

1988
- 1988-11-02 CA CA000581964A patent/CA1327358C/en not_active Expired - Lifetime
- 1988-11-07 EP EP88118515A patent/EP0316704B1/de not_active Expired - Lifetime
- 1988-11-07 ES ES88118515T patent/ES2074429T3/es not_active Expired - Lifetime
- 1988-11-07 AT AT88118515T patent/ATE124951T1/de active
- 1988-11-07 DE DE2001199027 patent/DE10199027I2/de active Active
- 1988-11-07 DE DE3854148T patent/DE3854148D1/de not_active Expired - Lifetime
- 1988-11-08 US US07/268,437 patent/US4966891A/en not_active Expired - Lifetime
- 1988-11-10 NZ NZ226923A patent/NZ226923A/xx unknown
- 1988-11-10 YU YU209188A patent/YU47122B/sh unknown
- 1988-11-10 ZA ZA888428A patent/ZA888428B/xx unknown
- 1988-11-11 IL IL88363A patent/IL88363A0/xx not_active IP Right Cessation
- 1988-11-14 HU HU885799A patent/HU199866B/hu unknown
- 1988-11-14 JP JP63285940A patent/JPH0678350B2/ja not_active Expired - Lifetime
- 1988-11-14 MC MC882015A patent/MC1992A1/fr unknown
- 1988-11-15 CS CS747588A patent/CS274486B2/cs not_active IP Right Cessation
- 1988-11-15 KR KR1019880014983A patent/KR970000241B1/ko not_active Expired - Lifetime
- 1988-11-16 PT PT89009A patent/PT89009B/pt not_active IP Right Cessation
- 1988-11-16 NO NO885106A patent/NO171167C/no not_active IP Right Cessation
- 1988-11-16 IS IS3412A patent/IS1895B/is unknown
- 1988-11-16 SU SU884356869A patent/SU1736342A3/ru active
- 1988-11-16 DK DK640388A patent/DK170893B1/da not_active IP Right Cessation
- 1988-11-16 DZ DZ880179A patent/DZ1270A1/fr active
- 1988-11-16 PH PH37820A patent/PH25641A/en unknown
- 1988-11-16 CN CN88107886A patent/CN1022688C/zh not_active Expired - Lifetime
- 1988-11-16 IE IE883430A patent/IE883430L/xx not_active IP Right Cessation
- 1988-11-16 UA UA4356869A patent/UA19333A/uk unknown
- 1988-11-16 AR AR88312471A patent/AR247217A1/es active
- 1988-11-16 AU AU25168/88A patent/AU619220B2/en not_active Expired
- 1988-11-17 FI FI885329A patent/FI89804C/fi not_active IP Right Cessation
- 1988-11-17 MX MX013836A patent/MX173347B/es unknown
1993
- 1993-06-08 LV LV930507A patent/LV5624A3/xx unknown
- 1993-07-20 LT LTRP802A patent/LT2185B/xx not_active IP Right Cessation
1995
- 1995-10-10 GR GR950402791T patent/GR3017686T3/el unknown
1998
- 1998-03-17 HK HK98102225A patent/HK1003114A1/xx not_active IP Right Cessation
2001
- 2001-05-02 LU LU90769C patent/LU90769I2/fr unknown
- 2001-05-17 NL NL300045C patent/NL300045I2/nl unknown
- 2001-07-17 NO NO2001013C patent/NO2001013I2/no unknown

Also Published As

Publication number	Publication date
IE883430L (en)	1989-05-17
NO885106L (no)	1989-05-18
AU2516888A (en)	1989-05-25
LT2185B (lt)	1993-10-15
EP0316704B1 (de)	1995-07-12
YU47122B (sh)	1994-12-28
PT89009A (pt)	1988-12-01
JPH0678350B2 (ja)	1994-10-05
NO885106D0 (no)	1988-11-16
PH25641A (en)	1991-08-21
US4966891A (en)	1990-10-30
ATE124951T1 (de)	1995-07-15
FI89804B (fi)	1993-08-13
DK640388A (da)	1989-05-18
DE3854148D1 (de)	1995-08-17
EP0316704A2 (de)	1989-05-24
CS747588A2 (en)	1990-09-12
ES2074429T3 (es)	1995-09-16
CS274486B2 (en)	1991-04-11
NL300045I1 (nl)	2001-08-01
DZ1270A1 (fr)	2004-09-13
NZ226923A (en)	1990-10-26
FI89804C (fi)	1993-11-25
NL300045I2 (nl)	2002-01-02
LU90769I2 (fr)	2001-07-02
KR970000241B1 (ko)	1997-01-08
AU619220B2 (en)	1992-01-23
NO171167B (no)	1992-10-26
UA19333A (uk)	1997-12-25
DE10199027I1 (de)	2001-08-02
FI885329A0 (fi)	1988-11-17
HUT48267A (en)	1989-05-29
SU1736342A3 (ru)	1992-05-23
FI885329L (fi)	1989-05-18
CA1327358C (en)	1994-03-01
DE10199027I2 (de)	2002-01-31
KR890008162A (ko)	1989-07-10
HK1003114A1 (en)	1998-10-09
GR3017686T3 (en)	1996-01-31
DK640388D0 (da)	1988-11-16
CN1022688C (zh)	1993-11-10
CN1033183A (zh)	1989-05-31
IS1895B (is)	2003-10-20
JPH01153696A (ja)	1989-06-15
NO171167C (no)	1993-02-03
YU209188A (en)	1990-08-31
LV5624A3 (lv)	1994-05-10
MC1992A1 (fr)	1989-11-30
DK170893B1 (da)	1996-03-04
IS3412A7 (is)	1989-05-18
PT89009B (pt)	1993-02-26
MX173347B (es)	1994-01-03
ZA888428B (en)	1989-06-28
NO2001013I2 (no)	2006-05-01
AR247217A1 (es)	1994-11-30
EP0316704A3 (en)	1990-11-22
HU199866B (en)	1990-03-28
MX13836A (es)	1993-10-01

Publication	Publication Date	Title
IL88363A0 (en)	1989-06-30	Fluorocytidine derivatives,their production and pharmaceutical compositions containing them
IL88184A0 (en)	1989-06-30	Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL87972A0 (en)	1989-03-31	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives,their preparation and pharmaceutical compositions containing them
IL85972A0 (en)	1988-09-30	Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL86798A (en)	1992-12-01	2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
IL83659A0 (en)	1988-01-31	Xanthine derivatives,their production and pharmaceutical compositions containing them
IL87949A0 (en)	1989-03-31	Dideoxycytidine derivatives,their preparation and pharmaceutical compositions containing them
IL84765A0 (en)	1988-05-31	Pyridazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL89752A0 (en)	1989-09-28	Bisphosphonates,their production and pharmaceutical compositions containing them
IL87644A0 (en)	1989-02-28	Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL87374A0 (en)	1989-01-31	Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL76546A0 (en)	1986-02-28	Purine derivatives,their preparation and pharmaceutical compositions containing them
IL86890A0 (en)	1988-11-30	Thiourea derivatives,their preparation and pharmaceutical compositions containing them
IL88927A0 (en)	1989-08-15	Thienoazepines,their production and pharmaceutical compositions containing them
IL88002A0 (en)	1989-06-30	2,2-dimethylchromene derivatives,their preparation and pharmaceutical compositions containing them
ZA887211B (en)	1989-05-30	Alkadiene derivatives,their preparation,and pharmaceutical compositions containing them
IL83049A0 (en)	1987-12-31	4-pyridone derivatives,their manufacture and pharmaceutical compositions containing them
IL85722A0 (en)	1988-08-31	Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
IL88138A0 (en)	1989-06-30	Purine derivatives,their preparation and pharmaceutical compositions containing them
IL86394A0 (en)	1988-11-15	Pyridine derivatives,their manufacture and pharmaceutical compositions containing them
IL92634A0 (en)	1990-08-31	Adenosine derivatives,their preparation and pharmaceutical compositions containing them
IL85970A0 (en)	1988-09-30	Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL74803A0 (en)	1985-07-31	Purine derivatives,their preparation and pharmaceutical compositions containing them
IL88775A0 (en)	1989-07-31	Acyl derivatives,their manufacture and pharmaceutical compositions containing them
IL87016A (en)	1993-02-21	Phenylpiperidine derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title
1999-04-11	KB	Patent renewed
2003-01-12	KB	Patent renewed
2005-01-24	EXTP	Application for extension order is pending
2005-02-20	EXTG	Extension of patent term granted
2006-12-27	KB	Patent renewed
2008-08-10	EXTN	Extension order renewed
2009-12-24	EXTN	Extension order renewed
2010-11-30	EXTN	Extension order renewed
2011-06-30	EXTN	Extension order renewed
2012-06-28	EXTN	Extension order renewed
2014-01-30	EXP	Patent expired